Skip to content

Paternal age of 25 to 29 at conception resulted in the lowest risk of adult-onset hormone related cancers in their daughters. From Science Daily:

Father's age at birth may affect daughter's cancer risk

Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer).

A team of City of Hope researchers, lead by Yani Lu, Ph.D., explored this relationship and found that a parent’s age at birth, particularly a father’s age, may affect the adult-onset cancer risk for daughters — especially for breast cancer.

“Our findings indicate that parental age, especially paternal age, at conception appears to be associated with a wide range of effects on the health and development of the offspring,” Lu said.

To help determine the effects of parental age on the risk of adult-onset hormone-related cancers, Lu and her colleagues examined a cohort of 133,479 female teachers and administrators from the California Teachers Study. Between 1995 and 2010, 5,359 women were diagnosed with breast cancer, 515 women were diagnosed with ovarian cancer and 1,110 women were diagnosed with endometrial cancer.

While the team of researchers did not find an association for maternal age at birth for any type of cancer, they found that paternal age is linked to an increased adult-onset cancer risk for daughters – and the link was not only to advanced paternal age.

Women born to a father under the age of 20 had a 35 percent greater risk of breast cancer and more than two times greater risk of ovarian cancer, when compared to those born to a father whose age at his daughter’s birth was 25 to 29 years old.

Women born to a father whose age at childbirth was 30 to 34 years had a 25 percent greater risk of endometrial cancer than those born to a father age 25 to 29.

Lu and her team were not surprised to find a relationship between older fathers and an increased risk of hormone-related cancers, especially since there has been increasing evidence suggesting that daughters born to older fathers have increased risk of breast cancer, noted Lu.

“We observed that young paternal age, as well as advanced paternal age, increase the risk of breast cancer,” said Lu. “We also found that young paternal age increases the risk of ovarian cancer.”

This exciting research opens a whole new way of thinking about the female breast and breast cancer. First of all, note that the study found that even our breasts have a microbiome (the microbial community).

Key finding: the breast microbial population (specifically the bacteria) is different in healthy breasts (in the breast tissue) as compared to cancerous breasts.

From Science Daily: First look at breast microbiota raises tantalizing questions

The female breast contains a unique population of microbes relative to the rest of the body, according to the first-ever study of the breast microbiome. That study sought to lay the groundwork for understanding how this bacterial community contributes to health and disease, says first author Camilla Urbaniak, a PhD student at the University of Western Ontario. 

"Proteobacteria was the dominant phylum in healthy breast tissue," says Urbaniak, noting that it is found only in small proportions at other sites in the body. That may reflect the fact that breast tissue produces high concentrations of fatty acids, and these bacteria are fatty acid metabolizers. Proteobacteria is also the predominant phylum in human milk.

"The fact that beneficial bacteria, such as Lactobacillus and Bifidobacteria, were also detected makes us wonder whether their presence might be protective for both mother and child," says principal investigator Gregor Reid of the University of Western Ontario. Breast milk is one of the initial sources of gastrointestinal (GI) bacteria for newborns, and their GI microbiota are different if they are formula fed, says Urbaniak.

Conversely, Escherichia and Bacillus predominated in cancerous breasts.

"Strains of Escherichia have been shown to have mutagenic and carcinogenic activity in the gut and the bladder," says Urbaniak.

In the study, the investigators collected breast tissue from 81 women. Ten of these had undergone breast reduction, and their breast microbiota served as controls. The remaining women had had benign or cancerous tumors. The tissue collected from these women was taken from about five centimeters from the tumor, from what is known as "normal adjacent" tissue. Bacterial censuses were taken using a molecular technique known as 16S ribosomal sequencing, and with cultures.

Studies of the microbiome in other parts of the body, most notably the gastrointestinal tract, have shown that certain changes in bacterial populations can lead to a variety of ills, from obvious gastrointestinal conditions such as inflammatory bowel disease to those more unexpected, such as diabetes, obesity, cancer and even neurological conditions.

The complete reference: C. Urbaniak, J. Cummins, M. Brackstone, J. M. Macklaim, G. B. Gloor, C. K. Baban, L. Scott, D. M. O'Hanlon, J. P. Burton, K. P. Francis, M. Tangney, G. Reid.Bacterial microbiota of human breast tissueApplied and Environmental Microbiology, 2014; DOI: 10.1128/AEM.00242-14

Hopefully these research results hold up for humans. But just the possibility is a wonderful and delicious reason to eat peaches. From Science Daily:

Peaches inhibit breast cancer metastasis in mice

Lab tests at Texas A&M AgriLife Research have shown that treatments with peach extract inhibit breast cancer metastasis in mice.

AgriLife Research scientists say that the mixture of phenolic compounds present in the peach extract are responsible for the inhibition of metastasis, according to the study, which was this month published in the Journal of Nutritional Biochemistry.

"Cancer cells were implanted under the skin of mice with an aggressive type of breast cancer cells, the MDA-MB-435, and what we saw was an inhibition of a marker gene in the lungs after a few weeks indicating an inhibition of metastasis when the mice were consuming the peach extract," said Dr. Luis Cisneros-Zevallos, a food scientist for AgriLife Research in College Station. "Furthermore, after determining the dose necessary to see the effects in mice, it was calculated that for humans it would be equivalent to consuming two to three peaches per day."

This work builds upon previous work at AgriLife Research released a few years ago, which showed that peach and plum polyphenols selectively killed aggressive breast cancer cells and not the normal ones, Cisneros-Zavallos said.

In the western hemisphere, breast cancer is the most common malignant disease for women, he said. In the U.S. last year, the American Cancer Society estimated about 232,340 new cases of invasive breast cancer among women.

The study was conducted using the peach variety Rich Lady. However, according to Cisneros-Zevallos, most peach fruit share similar polyphenolic compounds but might differ in content

"In general, peach fruit has chemical compounds that are responsible for killing cancer cells while not affecting normal cells as we reported previously, and now we are seeing that this mixture of compounds can inhibit metastasis," said Cisneros-Zevallos. "We are enthusiastic about the idea that perhaps by consuming only two to three peaches a day we can obtain similar effects in humans. However, this will have to be the next step in the study for its confirmation."

Another study discussing how physical activity reduces the risk of breast cancer for women of all ages and sizes. From Science Daily:

Regular physical activity reduces breast cancer risk irrespective of age

Practicing sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also unaffected by geographical location, according to research presented to the 9th European Breast Cancer Conference (EBCC-9). Compared with the least active women, those with the highest level of physical activity reduced their risk of breast cancer by 12%, researchers say.

Professor Mathieu Boniol, Research Director at the International Prevention Research Institute, Lyon, France, recently reported the results of a meta-analysis of 37 studies published between 1987 and 2013, representing over four million women. "These are all the studies looking at the relationship between physical exercise and breast cancer risk that have been published to date, so we are confident that the results of our analysis are robust," he said.

Although the results varied according to tumour type, the overall message was encouraging, the researchers say. However, in women taking hormone replacement therapy (HRT), the protective effect of exercise seemed to be cancelled out. But increased awareness of the side effects of HRT means that its use is decreasing in a number of countries, and this means that the beneficial effects of activity will most likely grow in the years to come. 

Physical activity is known to have a protective role in other cancers, as well as in disorders such as cardiovascular disease. Although the mechanisms for its effect are unclear, the results are largely independent of body mass index (BMI), so the effect must be due to more than weight control. And the age at which sporting activity starts also appears to be immaterial; the researchers found no indication that breast cancer risk would decrease only when physical activity started at a young age.

"Adding breast cancer, including its aggressive types, to the list of diseases that can be prevented by physical activity should encourage the development of cities that foster sport by becoming bike and walk-friendly, the creation of new sports facilities, and the promotion of exercise through education campaigns," said Prof Boniol. 

BPA is in many consumer products, but research is finding more and more problems with it. The findings of these two studies may motivate people to try to lower their exposure to plastics and BPA. From Newsweek:

BPA Levels Higher in Men With Prostate Cancer: Study

Bisphenol-A is everywhere. If you are reading this in the United States, there is a greater-than-90 percent chance you have BPA in your system, according to the Centers for Disease Control. The chemical is nearly ubiquitous: it is all over your receipts and soup cans, and it gives plastic bottles useful properties like flexibility and durability. It also mimics human estrogen in the body, and studies have linked it to breast cancer, diabetes, obesity, and hormone abnormalities in children, though what doses are dangerous is a matter of debate.

Now, for the first time, scientists are adding prostate cancer to the list of possible health problems from exposure.

Prostate cancer is the second most prevalent form of cancer among men, afflicting one in six, mostly later in life. A new study published Monday in the journal Plos One found that men with prostate cancer have BPA in their urine at levels 2- to 4-fold higher than cancer-free men. Aging is the best-known risk for prostate cancer, which makes the study’s findings particularly salient: BPA concentrations were especially high in prostate cancer patients under the age of 40, when aging is less of a contributing factor to the development of prostate cancer.

From Science Daily:

BPA linked to breast cancer tumor growth

UT Arlington biochemists say their newly published study brings researchers a step closer to understanding how the commonly used synthetic compound bisphenol-A, or BPA, may promote breast cancer growth.

Subhrangsu Mandal, associate professor of chemistry/biochemistry, and Arunoday Bhan, a PhD student in Mandal's lab, looked at a molecule called RNA HOTAIR. HOTAIR is an abbreviation for long, non-coding RNA, a part of DNA in humans and other vertebrates. HOTAIR does not produce a protein on its own but, when it is being expressed or functioning, it can suppress genes that would normally slow tumor growth or cause cancer cell death.

High levels of HOTAIR expression have been linked to breast tumors, pancreatic and colorectal cancers, sarcoma and others.

UT Arlington researchers found that when breast cancer and mammary gland cells were exposed to BPA in lab tests, the BPA worked together with naturally present molecules, including estrogen, to create abnormal amounts of HOTAIR expression. 

"We were surprised to find that BPA not only increased HOTAIR in tumor cells but also in normal breast tissue," said Bhan. He said further research is needed, but the results beg the question -- are BPA and HOTAIR involved in tumor genesis in addition to tumor growth?

BPA has been widely used in plastics, such as food storage containers, the lining of canned goods and, until recently, baby bottles. It belongs to a class of endocrine disrupting chemicals, or EDCs, which have been shown to mimic natural hormones. These endocrine disruptors interfere with hormone regulation and proper function of human cells, glands and tissue. 

Two studies about Vitamin D. From Science Daily:

Vitamin D increases breast cancer patient survival, study shows

Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of this nutrient, report University of California, San Diego School of Medicine researchers in the March issue of Anticancer Research.

In previous studies, Cedric F. Garland, DrPH, professor in the Department of Family and Preventive Medicine, showed that low vitamin D levels were linked to a high risk of premenopausal breast cancer. That finding, he said, prompted him to question the relationship between 25-hydroxyvitamin D -- a metabolite produced by the body from the ingestion of vitamin D -- and breast cancer survival rates.

Garland and colleagues performed a statistical analysis of five studies of 25-hydroxyvitamin D obtained at the time of patient diagnosis and their follow-up for an average of nine years. Combined, the studies included 4,443 breast cancer patients.

Women in the high serum group had an average level of 30 nanograms per milliliter (ng/ml) of 25-hydroxyvitamin D in their blood. The low group averaged 17 ng/ml. The average level in patients with breast cancer in the United States is 17 ng/ml.

A 2011 meta-analysis by Garland and colleagues estimated that a serum level of 50 ng/ml is associated with 50 percent lower risk of breast cancer. While there are some variations in absorption, those who consume 4,000 International Units (IU) per day of vitamin D from food or a supplement normally would reach a serum level of 50 ng/ml. 

From Science Daily:

Vitamin D deficiency may compromise immune function

Older individuals who are vitamin D deficient also tend to have compromised immune function, according to new research accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

"Our data suggest vitamin D may be involved in maintaining the health of the immune system as well as the skeletal system," said one of the study's authors, Mary Ward, PhD, of the University of Ulster in Coleraine, U.K.

The observational study of 957 Irish adults who were at least 60 years old examined vitamin D levels as well as biomarkers of inflammation. Participants who were vitamin D deficient were more likely to have high levels of these biomarkers, which are linked to cardiovascular disease and inflammatory conditions such as multiple sclerosis and rheumatoid arthritis.

Keep in mind that the Centers for Disease Control and Prevention (CDC) recommends that all adults take 400 micrograms of folic acid daily. From the January 21, 2014 Science Daily:

Large Amounts of Folic Acid Shown to Promote Growth of Breast Cancer in Rats

Folic acid supplements at levels consumed by breast cancer patients and survivors in North America promoted the growth of existing breast cancer in rats, new research found.

The role of folate, a B vitamin, and its synthetic form, folic acid, in the development and progression of breast cancer is highly controversial. Although some studies have found it may offer protection against breast cancer, recent studies have suggested that taking high amounts of folic acid may increase the risk of developing breast cancer.

Dr. Young-In Kim, a physician and researcher at St. Michael's Hospital, said his lab has shown for the first time that folic acid supplements in doses 2.5 to five times the daily requirement "significantly promotes" the growth of existing pre-cancerous or cancerous cells in the mammary glands of rats. 

This is a critically important issue because breast cancer patients and survivors in North America are exposed to high levels of folic acid through folic acid fortification in food and widespread use of vitamin supplements after a cancer diagnosis," Dr. Kim said. "Cancer patients and survivors in North America have a high prevalence of multivitamin and supplement use, with breast cancer patients and survivors having the highest prevalence."

A tomato rich diet may help protect women from breast cancer.From Science Daily:

Diet Rich in Tomatoes May Lower Breast Cancer Risk

A tomato-rich diet may help protect at-risk postmenopausal women from breast cancer, according to new research accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism.Breast cancer risk rises in postmenopausal women as their body mass index climbs. The study found eating a diet high in tomatoes had a positive effect on the level of hormones that play a role in regulating fat and sugar metabolism.

"The advantages of eating plenty of tomatoes and tomato-based products, even for a short period, were clearly evident in our findings," said the study's first author, Adana Llanos, PhD, MPH, who is an Assistant Professor of Epidemiology at Rutgers University. "Eating fruits and vegetables, which are rich in essential nutrients, vitamins, minerals and phytochemicals such as lycopene, conveys significant benefits. Based on this data, we believe regular consumption of at least the daily recommended servings of fruits and vegetables would promote breast cancer prevention in an at-risk population."

The longitudinal cross-over study examined the effects of both tomato-rich and soy-rich diets in a group of 70 postmenopausal women. For 10 weeks, the women ate tomato products containing at least 25 milligrams of lycopene daily. For a separate 10-week period, the participants consumed at least 40 grams of soy protein daily. Before each test period began, the women were instructed to abstain from eating both tomato and soy products for two weeks.

When they followed the tomato-rich diet, participants' levels of adiponectin -- a hormone involved in regulating blood sugar and fat levels -- climbed 9 percent. The effect was slightly stronger in women who had a lower body mass index.